On June 21, 2022 NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, reported that senior management will be hosting one-on-one meetings at the Truist Securities Cell Therapy Symposium – symposia-cel being held in person in New York City on Tuesday, June 28, 2022 (Press release, NKGEN Biotech, JUN 21, 2022, View Source [SID1234616129]). Details on the symposium can be found below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Truist Securities Cell Therapy Symposium – symposia-cel (in person)
Format: Symposium and 1 x 1 meetings
Date: Tuesday, June 28, 2022
Meeting Times: 12:30 pm – 5:00 pm EDT
Location: New York, NY
Registration: Event website

If you are interested in arranging a 1 x1 meeting with NKGen Biotech, please contact your Truist representative.